OxyContin

$650M Deal Means Firm Won’t Face Prosecution For Encouraging OxyContin Sales

The Justice Department will not prosecute a consulting firm accused of encouraging OxyContin sales in return for $650 million in resolution payments.

Continue Reading Take Me to More News

Supreme Court Rules OxyContin Makers Eligible For Civil Charges

The U.S. Supreme Court rejected a deal Thursday that would have shielded OxyContin makers from lawsuits over their role in the opioid epidemic. Critics say Purdue Pharma knew OxyContin was addictive when they aggressively pushed its sale.

Continue Reading Take Me to More News

More West Virginia News